Edwards Lifesciences announced the approval Monday for management of both pediatric and adult patients with severe pulmonary regurgitation on echocardiography who are candidates for surgical ...
For years, innovations in the treatment of pulmonary valve regurgitation have relied on invasive surgical treatments—until now. A device from Medtronic that takes a minimally invasive approach to ...
The FDA approved the world’s first nonsurgical heart valve device meant to treat patients with severe pulmonary valve regurgitation, which often is a result of congenital heart disease, the agency ...
The US Food and Drug Administration has approved the Harmony transcatheter pulmonary valve (TPV) system (Medtronic) as the first nonsurgical heart valve to treat pulmonary-valve regurgitation in ...
The US Food and Drug Administration (FDA) has cleared Edwards Lifesciences’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement, the manufacturer ...
EINDHOVEN, the Netherlands & ZURICH--(BUSINESS WIRE)--Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, today announced that it has started the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback